Tennessee Retina
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept (NCT03468296) | Tennessee Retina | 2018-04-01 |
Track Tennessee Retina automatically
Every clearance here is in the API, with alerts when new ones post.